Searching...Lobbying Arrangements: Pharmacy
New Lobbying Registrations About Pharmacy By Quarter
Former Covered Federal Workers:
Other Lobbyists:
| Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
|---|---|---|---|---|---|
| Details Strategy development and implementation of federal government relations initiatives relating to the Food and Drug Administrations Pre-Approval of Supplemental through New Drug Application (NDA). |
Galephar Pharmaceutical Research Inc.
|
Buchanan Ingersoll & Rooney, PC | |||
| Details Strategy development and implementation of federal government relations initiatives relating to the Food and Drug Administrations Pre-Approval of Supplemental through New Drug Application (NDA). |
Ohemo Life Sciences Inc.
|
Buchanan Ingersoll & Rooney, PC | |||
| Details Medical Countermeasures Development of Therapeutics for COVID-19 and Rare Disease |
Avalo Therapeutics
|
Burrell International Group LLC | |||
| Details Issues related to pharmaceutical manufacturing and supply |
Brownstein Hyatt Farber Schreck obo Medivant Healthcare
|
TGB STRATEGIES LLC | |||
| Details Issues related to competition and supply chain in the grocery industry, outreach regarding proposed merger with Krogers |
Albertsons Companies, Inc.
|
Ballard Spahr LLP | |||
| Details Issues related to pharmaceutical manufacturing and supply |
Medivant Healthcare
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
| Details Issues related to cannabis banking regulations. Issues related to regulation of medical cannabis. |
Columbia Care
|
FULCRUM PUBLIC AFFAIRS LLC | |||
| Details Issues related to animal drug compounding. Issues related to FDA's CVM GFI #256 - Compounding Animal Drugs from Bulk Substances. Issues related to animal drug compounding. FY 2024 Appropriations. |
Wedgewood Village Pharmacy, LLC
|
Mehlman Consulting, Inc. | |||
| Details Issues related to drug discovery, drug development, vaccine technologies, and coverage and reimbursement Issues related to international vaccine deployment |
ModernaTX, Inc.
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
| Details Issues related to the pharmaceutical industry; Issues related to Treating and Reducing Obesity. |
Eli Lilly and Company
|
FEROX STRATEGIES | |||
| Details Lobbied in support of including drug pricing reforms in the reconciliation bill/Build Back Better Act. Lobbied in support of efforts to lower drug prices through march-in or government use rights. ... |
Sixteen Thirty Fund
|
PORT SIDE STRATEGIES, LLC | |||
| Details COVID-19 preparedness products and services Diagnostic test reimbursement and policies H.R. 6102 VALID (Verifying Accurate Leadingedge IVCT Development) Act of 2020 Proposals related to COVID-19 me... |
REVVITY, INC. (FORMERLY PERKINELMER, INC.)
|
in-house lobbying | |||
| Details Issues related to counterfeit medicines and products; drug pricing; prescription drug importation from Canada and other foreign countries, PBM Reform and Accountability; prescription drug supply ch... |
Venture Global on behalf of The Partnership for Safe Medicines
|
STACEY BARRACK D/B/A STACEY BARRACK | |||
| Details Prescription drug pricing, telehealth, and vaccine issues. Monitoring federal legislation and outreach to congressional offices. |
GoodRx, Inc.
|
in-house lobbying | |||
| Details Issues regarding the availability and pricing of prescription drugs. |
EMD Serono, Inc.
|
Capitol Counsel, LLC | |||
| Details Issues related to coverage of pharmaceutical products. |
Agile Therapeutics
|
KEEFE SINGISER PARTNERS, FKA Keefe Strategies LLC | |||
| Details Appropriations for research related to use of therapeutics in pregnant and lactating people Policies related to COVID-19 vaccinations and pregnant and lactating people Policies related to implement... |
The Society for Maternal-Fetal Medicine
|
ARTEMIS POLICY GROUP LLC | |||
| Details Issues related to COVID-19 antiviral deployment - no specific legislation. |
PRN Software
|
K&L GATES LLP | |||
| Details Strategy development and implementation of federal government relations initiatives relating to generic animal drug industry. H.R. 1683, the Generic Animal Drug Advancement Act, all provisions; H.R... |
GENERIC ANIMAL DRUG ALLIANCE
|
Buchanan Ingersoll & Rooney, PC | |||
| Details Orphan drugs |
HypoPARAthyroidism Association
|
RUBICON ADVISORS, LLC | |||
| Details H.R. 6888/S. 4071, Helping Experts Accelerate Rare Treatments (HEART) Act [117th Congress] |
Chiesi USA, Inc.
|
THE KPM GROUP DC LLC | |||
| Details Delays in FDA inspection process. |
Nobelpharma America
|
M.J. Simon & Company, LLC | |||
| Details Rare disease issues. Orphan drugs. |
ASCENDIS PHARMA, INC.
|
in-house lobbying | |||
| Details Healthcare issues. Medicare and Medicaid issues. Medicare Advantage. Pharmacy benefit related issues. |
UnitedHealth Group, Inc.
|
Hannegan Landau Poersch & Rosenbaum Advocacy, LLC | |||
| Details Pandemic All-Health Preparedness Act reauthorization. Issues related to COVID-19 vaccine access and distribution. Issues related to the Strategic National Stockpile. Medicare dental health coverage... |
Henry Schein
|
Mehlman Consulting, Inc. | |||
| Details Grants and budget. |
Lorain County Community College
|
McCaulley&Company | |||
| Details Medical testing |
Visby Medical Inc.
|
Venable LLP | |||
| Details 505b2 regs |
eagle pha
|
awsom assoc | |||
| Details Issues related to surprise medical billing; S. 4185 End Surprise Medical Bills for Air Ambulances Act of 2020 |
Association of Air Medical Services
|
ANWAY LONG GROUP | |||
| Details Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Pharmacy Be... |
California Life Sciences Association
|
Forbes-Tate |